Cargando…

Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF

CONTEXT: Our previous studies indicated that Yiguanjian decoction (YGJ) has an anti-hepatic-fibrosis effect and could regulate macrophage status. OBJECTIVE: To elucidate the mechanism of YGJ in regulating macrophages. MATERIALS AND METHODS: Liver cirrhosis was induced by CCl(4) for 12 weeks combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ying, Xu, Wen, Liu, Wei, Chen, Gaofeng, Jiang, Shili, Chen, Jiamei, Jian, Xun, Zhang, Hua, Liu, Ping, Mu, Yongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436970/
https://www.ncbi.nlm.nih.gov/pubmed/34425061
http://dx.doi.org/10.1080/13880209.2021.1961820
_version_ 1783752086107717632
author Xu, Ying
Xu, Wen
Liu, Wei
Chen, Gaofeng
Jiang, Shili
Chen, Jiamei
Jian, Xun
Zhang, Hua
Liu, Ping
Mu, Yongping
author_facet Xu, Ying
Xu, Wen
Liu, Wei
Chen, Gaofeng
Jiang, Shili
Chen, Jiamei
Jian, Xun
Zhang, Hua
Liu, Ping
Mu, Yongping
author_sort Xu, Ying
collection PubMed
description CONTEXT: Our previous studies indicated that Yiguanjian decoction (YGJ) has an anti-hepatic-fibrosis effect and could regulate macrophage status. OBJECTIVE: To elucidate the mechanism of YGJ in regulating macrophages. MATERIALS AND METHODS: Liver cirrhosis was induced by CCl(4) for 12 weeks combined with 2-acetylaminofluorene (2-AAF) for the last 4 weeks in male Wistar rats. YGJ (3.56 mg/kg) orally administered in the last 4 weeks, and SORA (1 mg/kg) as control. In vitro, RAW264.7 cells were treated with lipopolysaccharides (LPSs) to induce macrophage polarization to the M1 phenotype, and they were co-cultured with WB-F344 cells and allocated to M group, YGJ group (2 μg/mL) and WIF-1 group (1 μg/mL) with untreated cells as control. The differentiation direction of WB-F344 cell line was observed in the presence or absence of YGJ. Pathology, fibrosis-related cytokines, macrophage polarization-related components, and Wnt signalling pathway components were detected. RESULTS: In vivo, the expression levels of α-SMA, Col (1), OV6, SOX9, EpCAM and M1 macrophage-related components (STAT1, IRF3, IRF5, IRF8, SOCS3) significantly decreased in the YGJ group compared with those in the 2-AAF/CCl(4) group (p < 0.01 or 0.05). In vitro, the expression levels of M1 macrophage-related components, including STAT1, NF-κB, IRF3, IRF5, and SOCS3, in RAW264.7 cells decreased significantly in the YGJ group compared with those in the M group (p < 0.05 or p < 0.01). The expression levels of Wnt3A, FZD5, LRP-5/-6, and β-catenin significantly increased in the YGJ group compared with those in the M group (p < 0.05 or p < 0.01). In addition, the expression levels of Wnt-4/-5A/-5B, and FZD2 significantly decreased in the YGJ group compared with those in the M group (p < 0.05 or p < 0.01). CONCLUSION: This study suggests that the anti-cirrhosis effect of YGJ is associated with its ability to inhibit macrophage M1-polarization, which provides a scientific basis for the clinical application of YGJ.
format Online
Article
Text
id pubmed-8436970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-84369702021-09-14 Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF Xu, Ying Xu, Wen Liu, Wei Chen, Gaofeng Jiang, Shili Chen, Jiamei Jian, Xun Zhang, Hua Liu, Ping Mu, Yongping Pharm Biol Research Article CONTEXT: Our previous studies indicated that Yiguanjian decoction (YGJ) has an anti-hepatic-fibrosis effect and could regulate macrophage status. OBJECTIVE: To elucidate the mechanism of YGJ in regulating macrophages. MATERIALS AND METHODS: Liver cirrhosis was induced by CCl(4) for 12 weeks combined with 2-acetylaminofluorene (2-AAF) for the last 4 weeks in male Wistar rats. YGJ (3.56 mg/kg) orally administered in the last 4 weeks, and SORA (1 mg/kg) as control. In vitro, RAW264.7 cells were treated with lipopolysaccharides (LPSs) to induce macrophage polarization to the M1 phenotype, and they were co-cultured with WB-F344 cells and allocated to M group, YGJ group (2 μg/mL) and WIF-1 group (1 μg/mL) with untreated cells as control. The differentiation direction of WB-F344 cell line was observed in the presence or absence of YGJ. Pathology, fibrosis-related cytokines, macrophage polarization-related components, and Wnt signalling pathway components were detected. RESULTS: In vivo, the expression levels of α-SMA, Col (1), OV6, SOX9, EpCAM and M1 macrophage-related components (STAT1, IRF3, IRF5, IRF8, SOCS3) significantly decreased in the YGJ group compared with those in the 2-AAF/CCl(4) group (p < 0.01 or 0.05). In vitro, the expression levels of M1 macrophage-related components, including STAT1, NF-κB, IRF3, IRF5, and SOCS3, in RAW264.7 cells decreased significantly in the YGJ group compared with those in the M group (p < 0.05 or p < 0.01). The expression levels of Wnt3A, FZD5, LRP-5/-6, and β-catenin significantly increased in the YGJ group compared with those in the M group (p < 0.05 or p < 0.01). In addition, the expression levels of Wnt-4/-5A/-5B, and FZD2 significantly decreased in the YGJ group compared with those in the M group (p < 0.05 or p < 0.01). CONCLUSION: This study suggests that the anti-cirrhosis effect of YGJ is associated with its ability to inhibit macrophage M1-polarization, which provides a scientific basis for the clinical application of YGJ. Taylor & Francis 2021-08-23 /pmc/articles/PMC8436970/ /pubmed/34425061 http://dx.doi.org/10.1080/13880209.2021.1961820 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xu, Ying
Xu, Wen
Liu, Wei
Chen, Gaofeng
Jiang, Shili
Chen, Jiamei
Jian, Xun
Zhang, Hua
Liu, Ping
Mu, Yongping
Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF
title Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF
title_full Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF
title_fullStr Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF
title_full_unstemmed Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF
title_short Yiguanjian decoction inhibits macrophage M1 polarization and attenuates hepatic fibrosis induced by CCl(4)/2-AAF
title_sort yiguanjian decoction inhibits macrophage m1 polarization and attenuates hepatic fibrosis induced by ccl(4)/2-aaf
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436970/
https://www.ncbi.nlm.nih.gov/pubmed/34425061
http://dx.doi.org/10.1080/13880209.2021.1961820
work_keys_str_mv AT xuying yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT xuwen yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT liuwei yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT chengaofeng yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT jiangshili yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT chenjiamei yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT jianxun yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT zhanghua yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT liuping yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf
AT muyongping yiguanjiandecoctioninhibitsmacrophagem1polarizationandattenuateshepaticfibrosisinducedbyccl42aaf